Premarket Mover: Phio Pharmaceuticals Corp (PHIO) Up 2.01%

Phio Pharmaceuticals Corp (PHIO) is higher by Monday morning, with the stock increasing 2.01% in pre-market trading to 1.52. PHIO's short-term technical score of 2 indicates that the stock has traded less bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 6% of stocks. Phio Pharmaceuticals Corp has fallen 9.70% over the past month, closing at $1.51 on September 18. During this period of time, the stock fell as low as $1.36 and as high as $3.23. PHIO has an average analyst recommendation of Strong Buy. The company has an average price target of $6.00.

PHIO has an Overall Score of 25. Find out what this means to you and get the rest of the rankings on PHIO!

See Full PHIO Report

Phio Pharmaceuticals Corp has a Long-Term Technical rank of 3. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 97% of the market scoring higher. In the Biotechnology industry which is number 137 by this metric, PHIO ranks better than 137% of stocks.

Important Dates for Investors in PHIO:

-Phio Pharmaceuticals Corp is set to release earnings on 2023-11-09. Over the last 12 months, the company has reported EPS of $-14.34. -We do not have a set dividend date for Phio Pharmaceuticals Corp at this time. Click Here To Get The Full Report on Phio Pharmaceuticals Corp (PHIO)